Our Resources

ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital data capture to remotely monitor patient vitals.

ObvioHealth, a full-service virtual research organization (VRO), announces today a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19

ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.

Singapore and New-York, 2 April 2020 – ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.

ObvioHealth, a global virtual research organization (VRO), and GI Alliance, one of the nation's largest independent gastroenterology services organization, jointly announce anew partnership to create better clinical trial experiences through the use of decentralized clinical trial designs.

NEW YORK – June 7, 2021 – ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.

ObvioHealth is excited to announce the completion of enrollment for its latest completely virtual research study. Our digital, disruption-free, approach to recruitment allowed participants to enroll from the safety of their homes.

ObvioHealth will integrate Hyfe's technology into its decentralized clinical trials platform and smartphone app to capture and analyze coughing events.